Acyclovir ZoviraxMD

Acyclovir (ZoviraxMD) antiviral and other Could be a viral infection to play an etiologic role in the pathogenesis of MS. This assumption was the basis used to achieve a double-blind, drugs, and random acyclovir in the treatment of herpes infections. Patients who received sixty RRMS acyclovir (800 mg) or placebo administered three times per day. Treatment was associated with activity has been reduced 34 percent. Percent in annual relapse rate, which confirms the value of further research and related vehicles acyclovir. In a recent study of magnetic resonance imaging (MRI) data on disease activity and showed no obvious effect valaciclovir, although positive results can not be denied in the subsets of September rights